Compounds > doripenem
Page last updated: 2024-08-25

doripenem and Acute Kidney Injury

doripenem has been researched along with Acute Kidney Injury in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Ide, N; Sato, S; Sawaguchi, K1
Broeker, A; Lipman, J; Roberts, JA; Thalhammer, F; Vossen, MG; Wallis, SC; Wicha, SG1
Boonpeng, A; Chaijamorn, W; Charoensareerat, T; Pattharachayakul, S; Puchsaka, P; Pummangura, C; Srisawat, N1
Bulitta, JB; Dunlop, R; Hayashi, Y; Jarrett, P; Lassig-Smith, M; Lipman, J; Roberts, JA; Roberts, NA; Starr, T; Stuart, J; Udy, AA; Wallis, SC1
Gaszynski, T; Gaszynski, W; Tokarz, A; Wieczorek, A1

Other Studies

5 other study(ies) available for doripenem and Acute Kidney Injury

ArticleYear
[Risk of Acute Kidney Injury in Patients Treated with Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Meropenem or Doripenem: A Retrospective Cohort Study].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2019, Volume: 139, Issue:12

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Doripenem; Drug Therapy, Combination; Female; Humans; Incidence; Logistic Models; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk; Vancomycin

2019
An Integrated Dialysis Pharmacometric (IDP) Model to Evaluate the Pharmacokinetics in Patients Undergoing Renal Replacement Therapy.
    Pharmaceutical research, 2020, May-14, Volume: 37, Issue:6

    Topics: Acute Kidney Injury; Adsorption; Anti-Bacterial Agents; Computer Simulation; Database Management Systems; Doripenem; Drug Stability; Humans; Metabolic Clearance Rate; Models, Biological; Prospective Studies; Renal Dialysis; Renal Replacement Therapy; Risk Assessment; Teicoplanin

2020
Doripenem dosing regimens in Asian critically ill patients with continuous renal replacement therapy.
    Journal of critical care, 2019, Volume: 52

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Body Weight; Continuous Renal Replacement Therapy; Critical Illness; Doripenem; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections

2019
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Plasma; Young Adult

2014
The doripenem serum concentrations in intensive care patients suffering from acute kidney injury, sepsis, and multi organ dysfunction syndrome undergoing continuous renal replacement therapy slow low-efficiency dialysis.
    Drug design, development and therapy, 2014, Volume: 8

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Carbapenems; Critical Care; Doripenem; Humans; Microbial Sensitivity Tests; Middle Aged; Multiple Organ Failure; Renal Dialysis; Sepsis

2014